SLF had a clinical efficacy on improving the liver function and FibroTouch, as well as relieving symptoms of fatigue
NAFLD, fatigue
LIVER
Liver function was tested for normality in both groups, and ALT, AST, and gamma glutamyl transpeptidase (GGT) did not conform to a normal distribution (SLF had a clinical efficacy on improving the liver function and FibroTouch, as well as relieving symptoms of fatigue. ALT, AST, GGT, CAP, LSM and FS-14 was compared in the two groups to evaluate the efficacy of SLF in liver function and FibroTouch, as well as the symptoms of fatigue. We also compared FibroTouch before and after treatment in both groups. There was no statistical difference in CAP between the two groups pre-treatment (In our clinical practice, we found that patients with NAFLD are often accompanied with fatigue symptoms. Therefore, we use the fatigue scale-14 (FS-14) to assess the fatigue symptoms of patients, which includes physical fatigue and mental fatigue (